Second cancer risk after chemotherapy for Hodgkin's lymphoma: A collaborative British cohort study

Journal of Clinical Oncology

Volumn 29, Issue 31, 2011, Pages 4096-4104

  Swerdlow, Anthony J ^a   Higgins, Craig D ^a   Smith, Paul ^c   Cunningham, David ^b   Hancock, Barry W ^e   Horwich, Alan ^a   Hoskin, Peter J ^f   Lister, T Andrew ^d   Radford, John A ^g   Rohatiner, Ama Z S ^d   Linch, David C ^c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^e WESTON PARK HOSPITAL   (United Kingdom)

^f MOUNT VERNON HOSPITAL   (United Kingdom)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE CANCER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; COLON CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; LEUKEMIA; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOUTH CANCER; NERVOUS SYSTEM TUMOR; NONHODGKIN LYMPHOMA; PANCREAS CANCER; PHARYNX CANCER; PLEURA CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; SECOND CANCER; SKIN CANCER; SMALL INTESTINE CANCER; SOFT TISSUE CANCER; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; TONGUE CANCER; UNITED KINGDOM; UTERINE CERVIX CANCER; UTERUS CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HODGKIN DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKEMIA; LUNG NEOPLASMS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 80755127111     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.34.8268     Document Type: Article

References (54)

1. Canellos GP, Arseneau JC, DeVita VT, et al.: Second malignancies complicating Hodgkin's disease in remission. Lancet 1:947-949, 1975
2. van Leeuwen FE, Swerdlow AJ, Travis LB: Second cancers after treatment of Hodgkin lymphoma, in Hoppe RT, Mauch PT, Armitage JO, et al. (eds): Hodgkin Lymphoma (ed 2). Philadelphia, PA, Lippincott Williams & Wilkins, 2007, pp 347-370
3. Swerdlow AJ, Douglas AJ, Hudson GV, et al.: Risk of second primary cancers after Hodgkin's disease by type of treatment: Analysis of 2,846 patients in the British National Lymphoma Investigation. BMJ 304:1137-1143, 1992
4. Kaldor JM, Day NE, Bell J, et al.: Lung cancer following Hodgkin's disease: A case-control study. Int J Cancer 52:677-681, 1992
5. Rodriguez MA, Fuller LM, Zimmerman SO, et al.: Hodgkin's disease: Study of treatment intensities and incidences of second malignancies. Ann Oncol 4:125-131, 1993 (Pubitemid 23061313)
6. Hancock SL, Tucker MA, Hoppe RT: Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85:25-31, 1993 (Pubitemid 23023219)
7. Mauch PM, Kalish LA, Marcus KC, et al.: Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: Long-term analysis of risk factors and outcome. Blood 87:3625-3632, 1996 (Pubitemid 26129590)
8. Birdwell SH, Hancock SL, Varghese A, et al.: Gastrointestinal cancer after treatment of Hodgkin's disease. Int J Radiat Oncol Biol Phys 37:67-73, 1997 (Pubitemid 27090135)
9. Abrahamsen JF, Andersen A, Hannisdal E, et al.: Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time, and age. J Clin Oncol 11:255-261, 1993 (Pubitemid 23046815)
10. van Leeuwen FE, Klokman WJ, van't Veer MB, et al.: Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 18:487-497, 2000 (Pubitemid 30078530)
11. Valagussa P, Santoro A, Fossati-Bellani F, et al.: Secondary acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 4:830-837, 1986 (Pubitemid 16080935)
12. Ng AK, Bernardo MVP, Weller E, et al.: Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Longterm risks and risk factors. Blood 100:1989-1996, 2002 (Pubitemid 35001228)
13. Bhatia S, Yasui Y, Robison LL, et al.: High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the Late Effects Study Group. J Clin Oncol 21:4386-4394, 2003 (Pubitemid 46621816)
14. Basu SK, Schwartz C, Fisher SG, et al.: Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. Int J Radiat Oncol Biol Phys 72:34-40, 2008
15. De Bruin ML, Burgers JA, Baas P, et al.: Malignant mesothelioma after radiation treatment for Hodgkin lymphoma. Blood 113:3679-3681, 2009
16. Kaldor JM, Day NE, Clarke EA, et al.: Leukemia following Hodgkin's disease. N Engl J Med 322:7-13, 1990 (Pubitemid 20023826)
17. van Leeuwen FE, Klokman WJ, Stovall M, et al.: Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst 87:1530-1537, 1995
18. Travis LB, Gospodarowicz M, Curtis RE, et al.: Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 94:182-192, 2002 (Pubitemid 34162752)
19. Travis LB, Hill DA, Dores GM, et al.: Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290:465-475, 2003 (Pubitemid 37430500)
20. van Leeuwen FE, Klokman WJ, Stovall M, et al.: Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 95:971-980, 2003 (Pubitemid 36896714)
21. Swerdlow AJ, Barber JA, Horwich A, et al.: Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. Br J Cancer 75:116-123, 1997 (Pubitemid 27007283)
22. Swerdlow AJ, Barber JA, Hudson GV, et al.: Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment. J Clin Oncol 18:498-509, 2000 (Pubitemid 30078531)
23. WHO: Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, Ninth Revision. Geneva, Switzerland, WHO, 1977
24. Swerdlow A, dos Santos Silva I, Doll R: Cancer Incidence and Mortality in England and Wales: Trends and Risk Factors. Oxford, United Kingdom, Oxford University Press, 2001
25. Breslow NE, Day NE: Statistical Methods in Cancer Research, Volume II: The Design and Analysis of Cohort Studies - IARC Scientific Publications No. 82. Lyon, France, IARC Press, 1987
26. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
27. International Agency for Research on Cancer: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (vol 76). Lyon, France, IARC Press, 2000
28. van den Belt-Dusebout AW, Aleman BM, Besseling G, et al.: Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. Int J Radiat Oncol Biol Phys 75:1420-1429, 2009
29. Teta MJ, Lau E, Sceurman BK, et al.: Therapeutic radiation for lymphoma: Risk of malignant mesothelioma. Cancer 109:1432-1438, 2007 (Pubitemid 46466572)
30. Tucker MA, Coleman CN, Cox RS, et al.: Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 318:76-81, 1988 (Pubitemid 18029298)
31. Henry-Amar M: Second cancer after the treatment for Hodgkin's disease: A report from the International Database on Hodgkin's Disease. Ann Oncol 3:117-128, 1992 (suppl 4)
32. Biti G, Cellai E, Magrini SM, et al.: Second solid tumors and leukemia after treatment for Hodgkin's disease: An analysis of 1121patients from a single institution. Int J Radiat Oncol Biol Phys 29:25-31, 1994 (Pubitemid 24138861)
33. van Leeuwen FE, Chorus AM, van den Belt-Dusebout AW, et al.: Leukemia risk following Hodgkin's disease: Relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. J Clin Oncol 12:1063-1073, 1994 (Pubitemid 24145338)
34. Boivin JF, Hutchison GB, Zauber AG, et al.: Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 87:732-741, 1995
35. Bhatia S, Robison LL, Oberlin O, et al.: Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334:745-751, 1996 (Pubitemid 26089355)
36. Bonadonna G, Viviani S, Bonfante V, et al.: Survival in Hodgkin's disease patients: Report of 25 years of experience at the Milan Cancer Institute. Eur J Cancer 41:998-1006, 2005 (Pubitemid 40602851)
37. Leong C, Ngeow J, Tan I, et al.: Second hematologic malignancies after ABVD: Two case reports and a retrospective study of 183 Hodgkin lymphoma patients. Acta Oncol 49:257-259, 2010
38. Valagussa PA, Bonadonna G: Carcinogenic effects of cancer treatment, in Peckham M, Pinedo H, Veronesi U (eds): Oxford Textbook of Oncology. Oxford, United Kingdom, Oxford University Press, 1995, pp 2348-2358
39. Delwail V, Jais JP, Colonna P, et al.: Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus highdose irradiation. Br J Haematol 118:189-194, 2002 (Pubitemid 34779536)
40. Sont JK, van Stiphout WA, Noordijk EM, et al.: Increased risk of second cancers in managing Hodgkins disease: The 20-year Leiden experience. Ann Hematol 65:213-218, 1992
41. Metayer C, Lynch CF, Clarke EA, et al.: Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 18:2435-2443, 2000 (Pubitemid 30415831)
42. Dores GM, Metayer C, Curtis RE, et al.: Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years. J Clin Oncol 20:3484-3494, 2002
43. Swerdlow AJ, Schoemaker MJ, Allerton R, et al.: Lung cancer after Hodgkin's disease: A nested case-control study of the relation to treatment. J Clin Oncol 19:1610-1618, 2001 (Pubitemid 32230860)
44. van Leeuwen FE, Klokman WJ, Hagenbeek A, et al.: Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 12:312-325, 1994 (Pubitemid 24056405)
45. Kenney LB, Yasui Y, Inskip PD, et al.: Breast cancer after childhood cancer: A report from the Childhood Cancer Survivor Study. Ann Intern Med 141:590-597, 2004 (Pubitemid 39390536)
46. Inskip PD, Robison LL, Stovall M, et al.: Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol 27:3901-3907, 2009
47. De Bruin ML, Sparidans J, van't Veer MB, et al.: Breast cancer risk in female survivors of Hodgkin's lymphoma: Lower risk after smaller radiation volumes. J Clin Oncol 27:4239-4246, 2009
48. Boice JD Jr: Ionizing radiation, in Scholtenfeld D, Fraumeni JF Jr (eds): Cancer Epidemiology and Prevention (ed 3). New York, NY, Oxford University Press, 2006, pp 259-293
49. Tucker MA, D'Angio GJ, Boice JD Jr, et al.: Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 317:588-593, 1987 (Pubitemid 17126781)
50. Hawkins MM, Wilson LM, Burton HS, et al.: Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 88:270-278, 1996 (Pubitemid 26073371)
51. Krikorian JG, Burke JS, Rosenberg SA, et al.: Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. N Engl J Med 300:452-458, 1979 (Pubitemid 9134789)
52. Marafioti T, Hummel M, Anagnostopoulos I, et al.: Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. J Clin Oncol 17:3804-3809, 1999
53. Boivin JF, O'Brien K: Solid cancer risk after treatment of Hodgkin's disease. Cancer 61:2541-2546, 1988
54. Prosper F, Robledo C, Cuesta B, et al.: Incidence of non-Hodgkin's lymphoma in patients treated for Hodgkin's disease. Leuk Lymphoma 12:457-462, 1994 (Pubitemid 24082137)